Andrew Hardie to Carcinoma, Hepatocellular
This is a "connection" page, showing publications Andrew Hardie has written about Carcinoma, Hepatocellular.
Connection Strength
2.040
-
Limitation of Virtual Noncontrasted Images in Evaluation of a Liver Lesion Status Post Transarterial Chemoembolization. J Comput Assist Tomogr. 2016 Jul-Aug; 40(4):557-9.
Score: 0.435
-
Imaging Requirements for Utilization of T2*-Weighted Magnetic Resonance Imaging for Identification of Hepatocellular Carcinoma in Cirrhosis: Effect of Hepatic Iron Content. J Comput Assist Tomogr. 2015 Jul-Aug; 39(4):468-72.
Score: 0.406
-
Can the patient with cirrhosis be imaged for hepatocellular carcinoma without gadolinium?: Comparison of combined T2-weighted, T2*-weighted, and diffusion-weighted MRI with gadolinium-enhanced MRI using liver explantation standard. J Comput Assist Tomogr. 2011 Nov-Dec; 35(6):711-5.
Score: 0.315
-
Diagnostic accuracy of diffusion-weighted MRI for identifying hepatocellular carcinoma with liver explant correlation. J Med Imaging Radiat Oncol. 2011 Aug; 55(4):362-7.
Score: 0.310
-
Assessment of the diagnostic accuracy of T2*-weighted MR imaging for identifying hepatocellular carcinoma with liver explant correlation. Eur J Radiol. 2011 Dec; 80(3):e249-52.
Score: 0.296
-
The use of T2*-weighted multi-echo GRE imaging as a novel method to diagnose hepatocellular carcinoma compared with gadolinium-enhanced MRI: a feasibility study. Magn Reson Imaging. 2010 Feb; 28(2):281-5.
Score: 0.278